Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Sisram Medical stock

1696.HK
IL0011418113

Price

0.56
Today +/-
+0.02
Today %
+3.72 %

Sisram Medical stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Sisram Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Sisram Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Sisram Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Sisram Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Sisram Medical Stock Price History

DateSisram Medical Price
3/6/20250.56 undefined
3/5/20250.54 undefined
3/4/20250.51 undefined
3/3/20250.51 undefined
2/28/20250.50 undefined
2/27/20250.55 undefined
2/26/20250.51 undefined
2/25/20250.48 undefined
2/24/20250.47 undefined
2/21/20250.49 undefined
2/20/20250.48 undefined
2/19/20250.49 undefined
2/18/20250.47 undefined
2/17/20250.47 undefined
2/14/20250.46 undefined
2/13/20250.44 undefined
2/12/20250.45 undefined
2/11/20250.44 undefined
2/10/20250.44 undefined
2/7/20250.44 undefined
2/6/20250.45 undefined

Sisram Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Sisram Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sisram Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sisram Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sisram Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sisram Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sisram Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sisram Medical’s growth potential.

Sisram Medical Revenue, EBIT and net profit per share

DateSisram Medical RevenueSisram Medical EBITSisram Medical Net Income
2026e519.18 M undefined145.51 M undefined42.99 M undefined
2025e450.83 M undefined53.54 M undefined40.61 M undefined
2024e385.27 M undefined45.73 M undefined31.05 M undefined
2023359.29 M undefined39.94 M undefined31.5 M undefined
2022354.48 M undefined46.12 M undefined40.17 M undefined
2021294.29 M undefined42.95 M undefined31.25 M undefined
2020162.1 M undefined16.61 M undefined13.34 M undefined
2019173.52 M undefined23.17 M undefined20.79 M undefined
2018153.92 M undefined21.62 M undefined21.83 M undefined
2017136.89 M undefined19.1 M undefined11.05 M undefined
2016118.16 M undefined18.11 M undefined8.06 M undefined
2015110.41 M undefined17.79 M undefined7.81 M undefined
2014101.32 M undefined16.38 M undefined5.94 M undefined

Sisram Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20142015201620172018201920202021202220232024e2025e2026e
101110118136153173162294354359385450519
-8.917.2715.2512.5013.07-6.3681.4820.411.417.2416.8815.33
50.5051.8252.5453.6853.5954.9155.5656.4657.0661.0056.8848.6742.20
51576273829590166202219000
57811212013314031314042
-40.0014.2937.5090.91-4.76-35.00138.4629.03-22.50-29.035.00
-------------
-------------
352352352284.69442.16442.16442.16452.87466.77468.34000
-------------
Details

Keystats

Revenue and Growth

The Sisram Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Sisram Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2014201520162017201820192020202120222023
                   
36.7539.3741.61104.08104.46107.74116.37152.9281.4170.46
22.2722.6628.2135.2536.4949.4746.569.8880.3883.46
0002.263.542.20.98000
18.4321.521.9623.927.5233.0237.1964.2474.7280.55
2.152.123.21.013.394.284.1110.5714.0522.88
79.5985.6594.97166.5175.41196.72205.15297.6250.57257.35
1.742.052.352.322.7214.2546.1645.4652.262.91
0000000.171.396.186.16
000007.0510.6212.5513.0512.91
76.5271.9867.0964.0459.0958.6353.2851.2245.29136.07
108.35108.35108.35108.35108.35111.18111.18111.18111.18126.92
4.184.976.45.414.5155.2410.7477.1411.2
190.79187.35184.19180.12174.67196.12226.66232.53305.04356.15
270.38272.99279.16346.62350.08392.83431.81530.13555.6613.5
                   
0001.251.251.251.251.331.331.33
111240.77240.77240.77240.77319.87321.53323.07
24.1931.8940.0450.9172.7384.0788.4580.36113.24132.89
-0.06-0.34-0.550.04-0.65-0.521.420.63-5.23-4.99
0000000000
25.1232.5540.49292.98314.1325.57331.89402.18430.87452.31
7.256.917.376.746.9511.999.4413.0213.348
8.736.9911.613.0311.8115.9520.3939.639.5641.13
4.617.045.9110.433.246.1520.6220.5518.6129.98
009.850000000
8.7510.512.254.322.175.334.3410.398.629.14
29.3341.4446.9734.5224.1739.4254.7983.5680.1388.25
58.5948.5136.676.7606.8732.7331.2432.7235.54
13.1312.212.6110.6910.0810.659.919.418.6514.36
144.21138.3142.421.671.7210.332.492.311.895.83
215.93199.01191.719.1211.827.8445.1242.9543.2555.73
245.26240.45238.6853.6435.9867.2699.92126.51123.38143.98
270.38272.99279.16346.62350.08392.83431.81528.69554.25596.29
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Sisram Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Sisram Medical's financial health and stability.

Assets

Sisram Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Sisram Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Sisram Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Sisram Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201420152016201720182019202020212022
91011152224164144
555559101212
000000000
0-9-9-10-13-14-4-29-49
8876103715
322200000
034652178
221516171621253222
00-10-1-3-9-2-5
-8-2-4-44-453-33-46-52
-7-1-3-43-256-24-43-47
000000000
-12-80-48-9-3-5-6-6
000103000790
-16-12-1348-17-9-1255-17
-3.00-3.00-12.00-6.00-8.00---12.00-2.00
00000-5-6-4-9
01-119-465-1641-50
22.2314.9214.9716.2914.9717.8716.4629.4116.97
000000000

Sisram Medical stock margins

The Sisram Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sisram Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sisram Medical.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sisram Medical's sales revenue. A higher gross margin percentage indicates that the Sisram Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sisram Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sisram Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sisram Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sisram Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sisram Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sisram Medical Margin History

Sisram Medical Gross marginSisram Medical Profit marginSisram Medical EBIT marginSisram Medical Profit margin
2026e61.1 %28.03 %8.28 %
2025e61.1 %11.88 %9.01 %
2024e61.1 %11.87 %8.06 %
202361.1 %11.12 %8.77 %
202257.05 %13.01 %11.33 %
202156.7 %14.59 %10.62 %
202055.71 %10.25 %8.23 %
201955.25 %13.35 %11.98 %
201853.47 %14.05 %14.18 %
201753.47 %13.95 %8.07 %
201652.66 %15.33 %6.82 %
201551.96 %16.11 %7.08 %
201451.19 %16.16 %5.87 %

Sisram Medical Stock Sales Revenue, EBIT, Earnings per Share

The Sisram Medical earnings per share therefore indicates how much revenue Sisram Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Sisram Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sisram Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sisram Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sisram Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sisram Medical Revenue, EBIT and net profit per share

DateSisram Medical Sales per ShareSisram Medical EBIT per shareSisram Medical Earnings per Share
2026e1.11 undefined0 undefined0.09 undefined
2025e0.96 undefined0 undefined0.09 undefined
2024e0.82 undefined0 undefined0.07 undefined
20230.77 undefined0.09 undefined0.07 undefined
20220.76 undefined0.1 undefined0.09 undefined
20210.65 undefined0.09 undefined0.07 undefined
20200.37 undefined0.04 undefined0.03 undefined
20190.39 undefined0.05 undefined0.05 undefined
20180.35 undefined0.05 undefined0.05 undefined
20170.48 undefined0.07 undefined0.04 undefined
20160.34 undefined0.05 undefined0.02 undefined
20150.31 undefined0.05 undefined0.02 undefined
20140.29 undefined0.05 undefined0.02 undefined

Sisram Medical business model

Sisram Medical Ltd is a leading company in the field of medical technologies and offers innovative solutions in aesthetic and medical laser treatments. The company is headquartered in Israel and operates in over 100 countries worldwide. The history of Sisram Medical dates back to 1997 when the company El.En SpA was founded in Italy. El.En SpA is a global leading manufacturer of medical lasers and specializes in the production of laser systems. In 2013, the company became part of Shanghai Fosun Pharmaceutical Group Co., Ltd and Sisram Medical was established. The business model of Sisram Medical is based on the development and manufacturing of innovative medical laser systems. The company is divided into two main divisions: aesthetic and medical. The aesthetic division includes products for skin rejuvenation, hair removal, and body contouring. The medical division offers products for the treatment of skin diseases such as psoriasis, as well as medical laser systems for tumor removal and the treatment of gynecological and urological conditions. Among the products offered by Sisram Medical is the Harmony XL Pro System. This system is a versatile laser system used for the treatment of acne, pigmentation disorders, and wrinkles. The Soprano ICE Platinum Laser hair removal technology is also a popular method for permanently getting rid of unwanted hair. The V-Lase system is another product innovation from Sisram Medical and is used for the treatment of vaginal issues. Another important division of Sisram Medical is the medical laser systems. These systems are used for the treatment of various skin conditions such as psoriasis and eczema. The MonaLisa Touch system is another medical laser system used for the treatment of vaginal discomfort. Sisram Medical stands out from other medical laser manufacturers with its intensive research and development. The company conducts continuous research to develop new products and improve existing ones. It works closely with leading medical professionals to ensure that its laser systems meet the highest quality standards. Overall, Sisram Medical Ltd is an innovative company specializing in the development and manufacturing of medical laser systems. It offers products and solutions for aesthetic and medical applications and operates worldwide. Through intensive research and collaboration with experts, the company is able to offer high-quality products that meet the needs of customers. Sisram Medical is one of the most popular companies on Eulerpool.com.

Sisram Medical SWOT Analysis

Strengths

Sisram Medical Ltd has several strengths that contribute to its success:

  • Strong brand reputation in the medical industry.
  • Wide range of innovative medical devices and solutions.
  • Strong network of strategic partnerships with healthcare providers.
  • Well-established global distribution channels.
  • Experienced and knowledgeable management team.

Weaknesses

Although Sisram Medical Ltd has various strengths, it also faces certain weaknesses:

  • Relatively high production costs affecting profit margins.
  • Limited market penetration in certain geographical regions.
  • Dependency on a few key suppliers.
  • Requires continuous investment in research and development.
  • Vulnerability to changes in healthcare regulations.

Opportunities

Sisram Medical Ltd can capitalize on the following opportunities:

  • Increasing demand for advanced medical technologies worldwide.
  • Expansion into emerging markets with growing healthcare sectors.
  • Acquisition or partnership opportunities to enhance product portfolio.
  • Growing trend towards non-invasive and minimally invasive procedures.
  • Potential for introducing new products to address unmet medical needs.

Threats

Sisram Medical Ltd faces certain threats that may impact its growth and profitability:

  • Intense competition from existing and new players in the medical device market.
  • Economic downturns affecting healthcare spending and demand.
  • Stringent regulations and compliance requirements.
  • Rapid technological advancements leading to product obsolescence.
  • Currency fluctuations affecting international operations.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Sisram Medical Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Sisram Medical historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Sisram Medical shares outstanding

The number of shares was Sisram Medical in 2024 — This indicates how many shares 468.343 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Sisram Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sisram Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sisram Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sisram Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sisram Medical dividend history and estimates

In 2024, Sisram Medical paid a dividend amounting to 0.16 USD. Dividend means that Sisram Medical distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Sisram Medical provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Sisram Medical’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Sisram Medical's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Sisram Medical Dividend History

DateSisram Medical Dividend
2026e0.16 undefined
2025e0.16 undefined
2024e0.16 undefined
20230.17 undefined
20220.16 undefined
20210.07 undefined
20200.11 undefined
20190.1 undefined

Sisram Medical dividend payout ratio

In 2024, Sisram Medical had a payout ratio of 166.6%. The payout ratio indicates the percentage of the company's profits that Sisram Medical distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Sisram Medical represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Sisram Medical could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Sisram Medical's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Sisram Medical Payout Ratio History

DateSisram Medical Payout ratio
2026e190.31 %
2025e188.32 %
2024e166.6 %
2023216.01 %
2022182.35 %
2021101.45 %
2020364.24 %
2019212.77 %
2018216.01 %
2017216.01 %
2016216.01 %
2015216.01 %
2014216.01 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Sisram Medical.

Sisram Medical shareholders

%
Name
Stocks
Change
Date
71.42350 % Shanghai Fosun Pharmaceutical Group Co Ltd334,504,8002,593,60012/31/2023
0.26400 % Mellon Investments Corporation1,236,40027,2001/31/2025
0.24025 % China Universal Asset Management Co., Ltd.1,125,200-384,8006/30/2024
0.15768 % Dayan (Lior Moshe)738,500012/2/2024
0.12811 % China Southern Asset Management Co. Ltd.600,000-1,394,20012/31/2023
0.06718 % ETF Managers Group, LLC314,627011/30/2023
0.05338 % China Asset Management Co., Ltd.250,000250,0006/30/2024
0.04164 % Liu (Yi)195,000012/2/2024
0.01274 % Segall Bryant & Hamill, LLC59,664012/31/2024
0 % Tidal Investments LLC0-314,62712/31/2023
1
2
3

Sisram Medical Executives and Management Board

Mr. Lior Moshe Dayan

(52)
Sisram Medical Chief Executive Officer, Executive Director (since 2017)
Compensation 1.59 M

Mr. Chi Fung Chan

(43)
Sisram Medical Non-Executive Independent Director
Compensation 25,000

Ms. Jenny Chen

(42)
Sisram Medical Non-Executive Independent Director
Compensation 25,000

Mr. Heung Sang Fong

(62)
Sisram Medical Non-Executive Independent Director
Compensation 25,000

Mr. Kai Yu Liu

(52)
Sisram Medical Non-Executive Independent Director
Compensation 25,000
1
2

Most common questions regarding Sisram Medical

What values and corporate philosophy does Sisram Medical represent?

Sisram Medical Ltd represents values of innovation, integrity, and excellence in the medical industry. As a leading global provider of comprehensive medical aesthetic solutions, the company is committed to enhancing people's lives through advanced technologies and high-quality products. Sisram Medical Ltd prioritizes customer satisfaction and remains dedicated to delivering state-of-the-art solutions while upholding the highest ethical standards. With a strong focus on research and development, Sisram Medical Ltd continuously strives to pioneer advancements in medical aesthetics, ultimately leading to improved patient outcomes and increased market value.

In which countries and regions is Sisram Medical primarily present?

Sisram Medical Ltd is primarily present in multiple countries and regions worldwide. The company has a strong global presence and operates in various markets, including the United States, China, Europe, and Asia-Pacific. With its commitment to innovation and advanced medical technologies, Sisram Medical Ltd has successfully established a widespread presence in key healthcare markets around the globe.

What significant milestones has the company Sisram Medical achieved?

Sisram Medical Ltd has achieved several significant milestones in its journey. The company has successfully established itself as a global leader in the field of medical aesthetics and energy-based devices. Sisram Medical Ltd has continuously advanced its product portfolio, introducing innovative technologies and solutions for various medical and cosmetic procedures. With a strong focus on research and development, the company has received numerous accolades for its breakthrough products and cutting-edge technologies. Sisram Medical Ltd has also expanded its global presence, establishing strategic partnerships and collaborations to strengthen its market position. Overall, Sisram Medical Ltd has an impressive track record of achievements, cementing its reputation as a trusted and progressive player in the healthcare industry.

What is the history and background of the company Sisram Medical?

Sisram Medical Ltd is a leading global provider of energy-based aesthetic medical and minimally invasive surgical devices. Founded in 2000, the company has established a strong presence in the medical aesthetics market. Sisram Medical offers a wide range of innovative products and solutions designed to enhance beauty, improve health, and promote well-being. With a strong focus on research and development, Sisram Medical continuously strives to deliver cutting-edge technologies and advanced treatment options to its customers. The company has achieved significant growth and success over the years, and its commitment to excellence has made it a trusted name in the medical aesthetics industry.

Who are the main competitors of Sisram Medical in the market?

The main competitors of Sisram Medical Ltd in the market include leading players in the medical aesthetics industry such as Syneron Medical Ltd and Cutera Inc. These companies also specialize in providing a wide range of innovative and advanced aesthetic medical devices and solutions. However, Sisram Medical Ltd sets itself apart through its unique offerings and cutting-edge technologies that cater to the specific needs of its customers. With its strong market presence and commitment to excellence, Sisram Medical Ltd continues to establish itself as a formidable competitor in the medical aesthetics market.

In which industries is Sisram Medical primarily active?

Sisram Medical Ltd is primarily active in the healthcare and medical device industries.

What is the business model of Sisram Medical?

Sisram Medical Ltd operates through a business model focused on the development, manufacturing, and distribution of energy-based aesthetic medical and cosmetic devices. As a leading global provider, Sisram Medical offers a wide range of products designed to enhance procedures like hair removal, wrinkle reduction, body contouring, and skin rejuvenation. By leveraging their expertise in advanced technologies and medical aesthetics, Sisram Medical aims to cater to the growing demand for non-invasive and minimally invasive aesthetic procedures. With a strong commitment to innovation and customer satisfaction, Sisram Medical Ltd continues to strive in the aesthetic medical industry.

What is the P/E ratio of Sisram Medical 2025?

The Sisram Medical P/E ratio is 6.5.

What is the P/S ratio of Sisram Medical 2025?

The Sisram Medical P/S ratio is 0.59.

What is the Quality Investing of Sisram Medical?

The Quality Investing for Sisram Medical is 4/10.

What is the revenue of Sisram Medical 2025?

The expected Sisram Medical revenue is 450.83 M USD.

How high is the profit of Sisram Medical 2025?

The expected Sisram Medical profit is 40.61 M USD.

What is the business model of Sisram Medical

Sisram Medical is an international provider of high-tech medical technology, offering a wide range of innovative high-end products for use in aesthetic medicine and ophthalmic surgery. The company operates in three different business areas: aesthetic medicine, ophthalmology, and products for medical facilities. In the field of aesthetic medicine, the company offers various treatment options, including laser hair removal devices, ultrasound focus devices, and non-invasive skin tightening devices, among others. Sisram Medical is a joint venture between Chinese company Fosun Pharma and Israeli company Syneron Candela, founded in 2017. The company is headquartered in Yokneam, Israel, and has a presence in Europe, Asia, and the USA. In the field of ophthalmology, Sisram Medical offers lasers and accessories for various applications, including LASIK eye surgery and photodynamic therapy. The company also offers products for medical facilities with different focuses, such as patient monitoring systems, infusion systems, or medical sterilization devices. Sisram Medical aims to supply the market with innovative technologies and highest quality products. The company has established itself in the market primarily through its high innovation power and close collaboration with medical research institutions. Over the past years, Sisram Medical has successfully acquired numerous medium-sized companies in Europe and Asia to strengthen its presence in these markets. In the USA, the company is now one of the leading providers of medical laser devices. The company has further plans for the coming months and years to expand and deepen its business. Vertical integration and driving its own research and development projects are expected to play a central role. In terms of SEO optimization, for example, the names of the various laser devices or treatment options could be linked in the text to achieve better Google rankings. In summary, Sisram Medical Ltd offers a wide range of innovative medical technology products for use in the fields of aesthetic medicine, ophthalmology, and medical facilities. The company has many years of experience in the industry and a broad customer base. In the future, the focus will be on vertical integration and in-house research and development to establish itself as a market leader through even more innovative products.

What is the Sisram Medical dividend?

Sisram Medical pays a dividend of 0.16 USD distributed over payouts per year.

How often does Sisram Medical pay dividends?

The dividend cannot currently be calculated for Sisram Medical or the company does not pay out a dividend.

What is the Sisram Medical ISIN?

The ISIN of Sisram Medical is IL0011418113.

What is the Sisram Medical ticker?

The ticker of Sisram Medical is 1696.HK.

How much dividend does Sisram Medical pay?

Over the past 12 months, Sisram Medical paid a dividend of 0.17 USD . This corresponds to a dividend yield of about 30.7 %. For the coming 12 months, Sisram Medical is expected to pay a dividend of 0.16 USD.

What is the dividend yield of Sisram Medical?

The current dividend yield of Sisram Medical is 30.7 %.

When does Sisram Medical pay dividends?

Sisram Medical pays a quarterly dividend. This is distributed in the months of September, September, September, September.

How secure is the dividend of Sisram Medical?

Sisram Medical paid dividends every year for the past 8 years.

What is the dividend of Sisram Medical?

For the upcoming 12 months, dividends amounting to 0.16 USD are expected. This corresponds to a dividend yield of 28.11 %.

In which sector is Sisram Medical located?

Sisram Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sisram Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sisram Medical from 9/9/2024 amounting to 0.158 USD, you needed to have the stock in your portfolio before the ex-date on 8/26/2024.

When did Sisram Medical pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Sisram Medical in the year 2024?

In the year 2024, Sisram Medical distributed 0.173 USD as dividends.

In which currency does Sisram Medical pay out the dividend?

The dividends of Sisram Medical are distributed in USD.

All fundamentals about Sisram Medical

Our stock analysis for Sisram Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sisram Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.